IMPACT BIOMEDICAL INC.

For the period ended Dec 31, 2024. Filed Mar 28, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 28, 2025

IBO$4.62+6.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Changes in Stockholders’ Equity

Common Stock · Preferred Stock · Additional Paid-in · Accumulated · Total Impact · Non- controlling Interest in
Shares · Amount · Shares · Amount · Capital · Deficit · Equity · Subsidiary · Total
Balance, December 31, 2022	70,496,041	$70,000	-	$	-	$38,113,000	$(8,625,000)	$29,558,000	3,111,000	$32,669,000
Conversion of common stock to preferred stock	(60,496,041)	(60,000)	60,496,041		60,000	-	-	-	-	-
Net loss	-	-	-		-	-	(4,336,000)	(4,336,000)	(71,000)	(4,407,000)
Balance, December 31, 2023	10,000,000	$10,000	60,496,041		$60,000	$38,113,000	$(12,961,000)	$25,222,000	$3,040,000	$28,262,000
Balance, December 31, 2023	10,000,000	$10,000	60,496,041		$60,000	$38,113,000	$(12,961,000)	$25,222,000	$3,040,000	$28,262,000
Issuance of common stock, net of expenses	1,500,000	1,000	-		-	3,725,000	-	3,726,000	-	3,726,000
Fractional shares as a result of reverse stock split	3,955	-	-		-	-	-	-	-	-
Stock based payments	-	-	-		-	19,000	-	19,000	-	19,000
Net (loss) income	-	-	-		-	-	(24,708,000)	(24,708,000)	(62,000)	(24,770,000)
Balance, December 31, 2024	11,503,955	$11,000	60,496,041		$60,000	$41,857,000	$(37,669,000)	$4,259,000	$2,978,000	$7,237,000

Impact BioMedical Inc and Subsidiaries

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.